ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2015 American Transplant Congress

    Absence of Allograft TLR4 Receptor Signaling Attenuates Early Inflammation and Promotes Survival of Allografts Subjected to Prolonged Cold Ischemic Storage

    N. Kohei,1 T. Tanaka,1 H. Tsuda,1 D. Kish,1 K. Tanabe,2 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

    Endogenous memory CD8 T cells infiltrate MHC-mismatched cardiac allografts and produce IFN-γ in response to donor class І MHC within 24 hrs after graft reperfusion…
  • 2015 American Transplant Congress

    Th17-Mediated Alloimmune Responses Play a Key Role in Intestinal Allograft Rejection in Humans

    A. Kroemer, S. Wanta, J. Diaz, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein.

    The Georgetown Transplant Institute, Washington, DC.

    The majority of transplanted intestines still falls victim to allograft enteropathy, the underlying mechanisms of which are poorly understood. The purpose of this study was…
  • 2015 American Transplant Congress

    Outcomes Following Kidney Transplant With Low Level Positive Flow Cytometric Crossmatch

    C. Schinstock, F. Cosio, M. Gandhi, L. Cornell, M. Stegall.

    Mayo Clinic, Rochester, MN.

    Introduction: Highly-sensitized kidney transplant (KTx) candidates have difficulty finding a negative crossmatch donor. KTx with low level positive crossmatch might be the next best option.…
  • 2015 American Transplant Congress

    Angiotensin Receptor Antibody IgG1 Subclass Predicts Accelerated Graft Loss in Those Kidney Transplant Recipients Who Develop Biopsy Proven Transplant Glomerulopathy Irrespective of the Presence Or Absence of Donor Specific Anti HLA Antibodies

    R. Carroll,1 A. Phillippe,2 D. Dragun,2 T. Coates.1

    1Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; 2Centre for Cardiovascular Research, Charite Hospital, Berlin, Germany.

    We assessed the presence or absence of angiotensin receptor antibodies (ATRab) in all those Kidney Transplant Patients who have had biopsy proven transplant glomerulopathy (TG)…
  • 2015 American Transplant Congress

    Basiliximab Induction With Delayed Tacrolimus Initiation up to 14 Days Post Liver Transplantation Maintains Excellent Clinical Outcomes While Preserving Renal Function

    J. Werth, W. Ally, D. Maluf, S. Pelletier.

    University of Virginia Health System, Charlottesville, VA.

    Background: Calcineurin inhibitors are frequently delayed to allow for recovery of renal function after transplantation; however, there is a paucity of literature supporting a delay…
  • 2015 American Transplant Congress

    Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

    J. Bamoulid,1 A. Roodenburg,2 O. Staeck,1 C. Schoenemann,2 N. Lachmann,2 K. Budde.1

    1Nephrology, Charite Hospital-University of Medicine, Berlin, Germany; 2HLA Laboratory, Charite Hospital-University of Medicine, Berlin, Germany.

    A. Not all de novo donor-specific HLA antibodies (dnDSA) are causing immediate graft loss. The importance of complement-binding DSA was recently shown with a commercial…
  • 2015 American Transplant Congress

    Structural and Functional Basis for Non-HLA Antibody Mediated AT1R Activation

    D. Dragun, D. Postpieszala, N. Zhu, R. Catar, A. Philippe.

    Nephrology and Intensive Care Medicine, Charité University Hospital, Berlin, Germany.

    Angiotensin II type receptor (AT1R), a heptahelical protein signals stimuli upon binding of natural peptide ligand angiotensin II (Ang II) and the pathogenic non-HLA IgG…
  • 2015 American Transplant Congress

    Infectious Complications With Plasmapheresis in Combination With Antithymocyte Globulin Compared to Antithymocyte Globulin Alone in the Treatment of Acute Rejection

    A. Leino, A. Hulbert, A. Delahunty, A. Rajab, J. Von Visger, H. Winters.

    The Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH.

    Background: Due to the complex nature of acute rejection (AR), multiple therapeutic modalities are necessary to prevent graft loss. The combination of prolonged cell depletion…
  • 2015 American Transplant Congress

    The Potential Use of the Plasma Biomarker CXCL9 (MIG), Interleukin 2 Receptor alpha (IL2Rα) and SCGF-b as Predictors of Renal Graft Rejection

    C. Blume,1 S. Michael,2 N. Christine,3 H. Hermann,4 F. Christine.3

    1Technical Chemistry, Leibniz University, Hannover, Germany; 2Musculo Sceletal Reserach, University of Wuerzburg, Wuerzburg, Germany; 3Transplant Immunology, Medical School Hannover, Hannover, Germany; 4Dept. Nephrology, Medical School Hannover, Hannover, Germany.

    Background: Early detection of rejection in kidney transplantation is crucial, and predictive plasma biomarkers are highly desirable as non-invasive tests.Methods: From a cohort of 120…
  • 2015 American Transplant Congress

    Intra-Lymphocyte Concentrations of Mycophenolic Acid Correlate With the Incidence of Early Graft Rejection in Renal Transplant Recipients

    Z. Md Dom,2 J. Coller,2 R. Carroll,3 A. Somogyi,2 B. Sallustio.1

    1Clinical Pharmacology, The Queen Elizabeth Hospital, Adelaide, Australia; 2Discipline of Pharmacology, Univeristy of Adelaide, Adelaide, Australia; 3Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.

    Introduction: Although routine therapeutic drug monitoring of mycophenolic acid (MPA) concentrations in plasma has been recommended to individualize MPA doses in transplant recipients, little is…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences